Haemonetics Company Overview, Contact Details & Competitors

Insights

Gathering insights about Haemonetics…

Similar companies to Haemonetics

Haemonetics Tech Stack

Haemonetics uses 8 technology products and services including AutoCad, Lessonly, IBM, and more. Explore Haemonetics's tech stack below.

AutoCad
Cad & Graphics
Lessonly
Corporate Learning Management Systems
IBM
Miscellaneous
New Relic
Real User Monitoring
Skype
Unified Communications
Citrix
Virtualisation Software
Adobe Creative Suite
Visualisation Software
Microsoft ASP.NET
Web Frameworks

Media & News

CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE)
If approved, garadacimab will be the first and only once-monthly treatment inhibiting factor XIIa to prevent attacks in HAE patients – a community CSL has been serving for more than 40 years MARBURG, Germany , Dec. 13, 2024 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending granting a marketing authorization for garadacimab as a once-monthly prophylactic treatment for hereditary angioedema (HAE) in adult and adolescent patients aged 12 years and older. Garadacimab is a monoclonal antibody that targets activated factor XII (factor XIIa), a plasma protein that plays a key role in attacks of swelling in people with HAE, thereby inhibiting the HAE cascade at the top to prevent HAE attacks.
Dec 13, 2024 | www.prnewswire.com
Are Investors Undervaluing Haemonetics (HAE) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Dec 06, 2024 | www.zacks.com
Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 27.8% in Haemonetics (HAE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Dec 04, 2024 | www.zacks.com
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?
Haemonetics inks a new agreement to sell its whole blood assets to GVS. The transaction is expected to be closed in the first quarter of 2025.
Dec 04, 2024 | www.zacks.com
4 Medical Product Stocks to Buy From a Prospective Industry
An ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. RMD, HAE, PAHC and AGIO are well-poised to gain from the favorable factors.
Dec 04, 2024 | www.zacks.com
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
BOSTON , Dec. 3, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to sell its whole blood assets to GVS, S.p.A ("GVS"), one of the world's leading manufacturers of filter solutions for applications in the healthcare and life sciences sectors. The transaction comprises a total cash consideration of up to $67.1M, which includes $44.6M upfront and up to $22.5M in contingent earn-outs over the next four years.
Dec 03, 2024 | www.prnewswire.com
HAE or BSX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Nov 15, 2024 | www.zacks.com

Haemonetics's Email Address Formats

Haemonetics uses at least 1 format(s):

Haemonetics Email Formats	Example	Percentage
FLast@haemonetics.com	JDoe@haemonetics.com	58%
First.Last@haemonetics.com	John.Doe@haemonetics.com	38%
FiLast@haemonetics.com	JoDoe@haemonetics.com	2%
FirstLast@haemonetics.com	JohnDoe@haemonetics.com	2%

Frequently Asked Questions

Where is Haemonetics's headquarters located?

Haemonetics's main headquarters is located at Boston, MA 02110 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Haemonetics's phone number?

You can contact Haemonetics's main corporate office by phone at

+1-781-848-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Haemonetics's stock symbol?

Haemonetics is a publicly traded company; the company's stock symbol is HAE.

What is Haemonetics's official website and social media links?

Haemonetics's official website is haemonetics.com and has social profiles on LinkedIn.

How much revenue does Haemonetics generate?

As of November 2024, Haemonetics's annual revenue reached $993M.

What is Haemonetics's NAICS code?

Haemonetics's NAICS code is 339112 - Surgical and Medical Instrument Manufacturing.

How many employees does Haemonetics have currently?

As of November 2024, Haemonetics has approximately 2.5K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: D. G.Chief Financial Officer: J. D.Chief Information Security Officer And Data Protection Officer: S. D.. Explore Haemonetics's employee directory with LeadIQ.

What industry does Haemonetics belong to?

Haemonetics operates in the Medical Equipment Manufacturing industry.

What technology does Haemonetics use?

Haemonetics's tech stack includes AutoCadLessonlyIBMNew RelicSkypeCitrixAdobe Creative SuiteMicrosoft ASP.NET.

What is Haemonetics's email format?

Haemonetics's email format typically follows the pattern of . Find more Haemonetics email formats with LeadIQ.

How much funding has Haemonetics raised to date?

As of November 2024, Haemonetics has raised $600M in funding. The last funding round occurred on May 21, 2024 for $600M.

When was Haemonetics founded?

Haemonetics was founded in 1971.

Insights

Similar companies to Haemonetics

Grifols

Smiths Medical

Werfen

Medtronic

Danaher Corporation

Fresenius Kabi

Haemonetics Tech Stack

Media & News

CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE)

Are Investors Undervaluing Haemonetics (HAE) Right Now?

Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High?

Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?

4 Medical Product Stocks to Buy From a Prospective Industry

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

HAE or BSX: Which Is the Better Value Stock Right Now?

Haemonetics's Email Address Formats

Frequently Asked Questions

Where is Haemonetics's headquarters located?

What is Haemonetics's phone number?

What is Haemonetics's stock symbol?

What is Haemonetics's official website and social media links?

How much revenue does Haemonetics generate?

What is Haemonetics's NAICS code?

How many employees does Haemonetics have currently?

What industry does Haemonetics belong to?

What technology does Haemonetics use?

What is Haemonetics's email format?

How much funding has Haemonetics raised to date?

When was Haemonetics founded?

Haemonetics

Company Overview

Media & News

CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE)

Are Investors Undervaluing Haemonetics (HAE) Right Now?

Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High?

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?